PANACEA: application of Artificial intelligence in spectral photon-counting computed tomography

PAACEA：人工智能在光谱光子计数计算机断层扫描中的应用

• 批准号: 570539-2021
• 负责人: Bazalova, MagdalenaM
• 金额: $ 20.58万
• 依托单位: University of Victoria
• 依托单位国家: 加拿大
• 项目类别: Alliance Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-01-01 至 2023-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=762736
• 关键词: PANACEA; application; Artificial; intelligence; spectral

Medical x-ray imaging is currently experiencing a breakthrough thanks to the very recent approval of the first computed tomography (CT) scanner employing photon-counting detectors by the Food and Drug Agency (FDA). It is believed that photon counting CT scanners will drastically improve disease diagnosis by offering unprecedentedly high resolution and high contrast enabling the visualization of small features and early disease detection.Thanks to the past partnership between, Redlen Technologies and the X-ray Cancer Imaging and Therapy Experimental (XCITE) lab at the University of Victoria are extremely well positioned to make significant contributions to the novel field of CT imaging with photon-counting detectors. Redlen Technologies is a manufacturer of photon-counting detectors and is looking for academic partners with CT imaging software expertise who can fully unleash the potential of their photon-counting detectors for unprecedented high-resolution high-contrast CT imaging for the diagnosis of diseases, including cancer, stroke and COVID-19. The XCITE lab has extensive experience with CT imaging which they will marry with their machine learning for medical imaging expertise and will help solve the photo-counting CT imaging challenge posed by Redlen Technologies. In this partnership between Redlen Technologies and the XCITE lab, the team will join in the race to offer the highest quality healthcare and put Canada on the world map of experts in photon-counting CT scanner hardware and software.

由于美国食品和药物管理局（FDA）最近批准了第一台采用光子计数探测器的计算机断层扫描（CT）扫描仪，医疗X射线成像目前正在经历突破。人们相信，光子计数CT扫描仪将通过提供前所未有的高分辨率和高对比度，实现微小特征的可视化和早期疾病检测，从而大大改善疾病诊断。Redlen技术和X射线癌症成像和治疗实验（XCITE）实验室在维多利亚大学是非常好的定位作出重大贡献的新领域的CT成像与光子计数探测器。Redlen Technologies是光子计数探测器的制造商，正在寻找具有CT成像软件专业知识的学术合作伙伴，这些合作伙伴可以充分释放光子计数探测器的潜力，用于前所未有的高分辨率高对比度CT成像，用于诊断疾病，包括癌症，中风和COVID-19。XCITE实验室在CT成像方面拥有丰富的经验，他们将与机器学习结合起来，用于医学成像专业知识，并将帮助解决Redlen Technologies带来的照片计数CT成像挑战。在Redlen Technologies和XCITE实验室之间的合作中，该团队将加入竞争，提供最高质量的医疗保健，并将加拿大置于光子计数CT扫描仪硬件和软件专家的世界地图上。